The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Smither John W | Director | Sell(S) | 12K | $2.91 | $35K |
| Jun 16, 2026 | Pulisic Matthew | Chief Financial Officer | Grant(A) | 279K | — | $0 |
| Jun 16, 2026 | Groen Eric | General Counsel | Grant(A) | 234K | — | $0 |
| Jun 16, 2026 | Cappello Joseph | Chief Technical Officer | Grant(A) | 175K | — | $0 |
| Jun 16, 2026 | Tyree James L | Director | Grant(A) | 28K | — | $0 |
| Jun 16, 2026 | Tyree James L | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Thomas John | Director | Grant(A) | 28K | — | $0 |
| Jun 16, 2026 | Thomas John | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Zindrick Thomas | President and CEO | Grant(A) | 731K | — | $0 |
| Jun 16, 2026 | Mirabelli Mary | Director | Grant(A) | 28K | — | $0 |
| Jun 16, 2026 | Mirabelli Mary | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Yu Yong | Chief Scientific Officer | Grant(A) | 119K | — | $0 |
| Jun 16, 2026 | Smither John W | Director | Grant(A) | 28K | — | $0 |
| Jun 16, 2026 | Smither John W | Director | Grant(A) | 32K | — | $0 |
| Jun 3, 2026 | Smalling Ralph | Head of Regulatory | Sell(S) | 192 | $2.93 | $563 |
| Jun 1, 2026 | Thomas John | Director | Sell(S) | 10K | $2.98 | $30K |
| May 11, 2026 | Smalling Ralph | Head of Regulatory | Sell(S) | 270 | $2.98 | $804 |
| May 11, 2026 | Zindrick Thomas | President and CEO | Sell(S) | 3K | $2.94 | $8K |
| May 11, 2026 | Yu Yong | Chief Scientific Officer | Sell(S) | 605 | $2.97 | $2K |
| May 11, 2026 | Cappello Joseph | Chief Technical Officer | Sell(S) | 605 | $2.97 | $2K |
| Mar 25, 2026 | Smalling Ralph | Head of Regulatory | Sell(S) | 240 | $2.51 | $602 |
| Mar 24, 2026 | Zindrick Thomas | President and CEO | Sell(S) | 4K | $2.42 | $9K |
| Mar 24, 2026 | Yu Yong | SVP, Clinical Development | Sell(S) | 906 | $2.42 | $2K |
| Mar 24, 2026 | Cappello Joseph | Chief Technical Officer | Sell(S) | 906 | $2.42 | $2K |
| Mar 24, 2026 | Smalling Ralph | Head of Regulatory | Sell(S) | 345 | $2.42 | $835 |
| Mar 2, 2026 | Thomas John | Director | Sell(S) | 10K | $2.90 | $29K |
| Jan 2, 2026 | Litten Jason | Chief Medical Officer | Grant(A) | 275K | — | $0 |
| Dec 5, 2025 | Smalling Ralph | Head of Regulatory | Sell(S) | 165 | $4.69 | $774 |
| Dec 1, 2025 | Thomas John | Director | Sell(S) | 10K | $5.00 | $50K |
| Nov 17, 2025 | Smalling Ralph | Head of Regulatory | Sell(S) | 343 | $5.37 | $2K |
| Nov 17, 2025 | Cappello Joseph | Chief Technical Officer | Sell(S) | 973 | $5.37 | $5K |
| Nov 17, 2025 | Yu Yong | SVP, Clinical Development | Sell(S) | 973 | $5.37 | $5K |
| Nov 17, 2025 | Zindrick Thomas | President and CEO | Sell(S) | 5K | $5.37 | $24K |
| Sep 3, 2025 | Smalling Ralph | Head of Regulatory | Sell(S) | 580 | $3.36 | $2K |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Grant(A) | 65K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Disposed to issuer(D) | 65K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Grant(A) | 13K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Disposed to issuer(D) | 13K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Grant(A) | 80K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Disposed to issuer(D) | 80K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Disposed to issuer(D) | 17K | — | — |
| Sep 1, 2025 | Cappello Joseph | Chief Technical Officer | Grant(A) | 17K | — | — |
| Sep 1, 2025 | Smalling Ralph | Head of Regulatory | Grant(A) | 10K | — | $0 |
| Sep 1, 2025 | Smalling Ralph | Head of Regulatory | Disposed to issuer(D) | 8K | — | — |
| Sep 1, 2025 | Smalling Ralph | Head of Regulatory | Grant(A) | 8K | — | — |
| Sep 1, 2025 | Yu Yong | SVP, Clinical Development | Grant(A) | 65K | — | — |
| Sep 1, 2025 | Yu Yong | SVP, Clinical Development | Disposed to issuer(D) | 65K | — | — |
| Sep 1, 2025 | Yu Yong | SVP, Clinical Development | Grant(A) | 208K | — | — |
| Sep 1, 2025 | Yu Yong | SVP, Clinical Development | Disposed to issuer(D) | 208K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Disposed to issuer(D) | 157K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Disposed to issuer(D) | 24K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Disposed to issuer(D) | 925K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Disposed to issuer(D) | 250K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Grant(A) | 24K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Grant(A) | 157K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Grant(A) | 250K | — | — |
| Sep 1, 2025 | Zindrick Thomas | President and CEO, Director | Grant(A) | 925K | — | — |
| Aug 27, 2025 | Cappello Joseph | Chief Technical Officer | Grant(A) | 108K | — | $0 |
| Aug 27, 2025 | Cappello Joseph | Chief Technical Officer | Grant(A) | 143K | — | $0 |
| Aug 27, 2025 | Smalling Ralph | Head of Regulatory | Grant(A) | 26K | — | $0 |
| Aug 27, 2025 | Smalling Ralph | Head of Regulatory | Grant(A) | 35K | — | $0 |
| Aug 27, 2025 | Yu Yong | SVP, Clinical Development | Grant(A) | 101K | — | $0 |
| Aug 27, 2025 | Yu Yong | SVP, Clinical Development | Grant(A) | 135K | — | $0 |
| Aug 27, 2025 | Zindrick Thomas | President and CEO | Grant(A) | 361K | — | $0 |
| Aug 27, 2025 | Zindrick Thomas | President and CEO | Grant(A) | 479K | — | $0 |
| Aug 27, 2025 | Thomas John | Director | Grant(A) | 22K | — | $0 |
| Aug 27, 2025 | Thomas John | Director | Grant(A) | 29K | — | $0 |
| Aug 27, 2025 | Mirabelli Mary | Director | Grant(A) | 22K | — | $0 |
| Aug 27, 2025 | Mirabelli Mary | Director | Grant(A) | 29K | — | $0 |
| Aug 27, 2025 | Smither John W | Director | Grant(A) | 22K | — | $0 |
| Aug 27, 2025 | Smither John W | Director | Grant(A) | 29K | — | $0 |
| Aug 27, 2025 | Tyree James L | Director | Grant(A) | 22K | — | $0 |
| Aug 27, 2025 | Tyree James L | Director | Grant(A) | 29K | — | $0 |
| Aug 21, 2025 | Smalling Ralph | Head of Regulatory | Sell(S) | 1K | $3.36 | $4K |
| Aug 21, 2025 | Cappello Joseph | Chief Technical Officer | Sell(S) | 1K | $3.33 | $4K |
| Aug 21, 2025 | Cappello Joseph | Chief Technical Officer | Sell(S) | 1K | $3.36 | $5K |
| Aug 21, 2025 | Yu Yong | SVP, Clinical Development | Sell(S) | 3K | $3.36 | $11K |
| Aug 21, 2025 | Zindrick Thomas | President and CEO | Sell(S) | 13K | $3.33 | $42K |
| Jul 1, 2025 | Groen Eric | General Counsel & Secretary | Grant(A) | 270K | — | $0 |
| Jun 6, 2025 | Thomas John | Director | Gift(G) | 25K | — | $0 |
| May 12, 2025 | Smalling Ralph | Head of Regulatory | Sell(S) | 1K | $2.92 | $4K |
| May 12, 2025 | Cappello Joseph | VP, Pharmaceutical Development | Sell(S) | 5K | $2.92 | $14K |
| May 12, 2025 | Yu Yong | VP, Clinical Trial Operations | Sell(S) | 6K | $2.92 | $16K |
| May 12, 2025 | Zindrick Thomas | President and CEO, Director | Sell(S) | 11K | $2.92 | $31K |
| May 12, 2025 | Ryder Sean | General Counsel | Sell(S) | 4K | $2.92 | $13K |
| Mar 14, 2025 | Zindrick Thomas | President and CEO, Director | Grant(A) | 30K | — | $0 |
| Mar 14, 2025 | Ryder Sean | General Counsel | Grant(A) | 11K | — | $0 |
| Mar 14, 2025 | Yu Yong | VP, Clinical Trial Operations | Grant(A) | 13K | — | $0 |
| Mar 14, 2025 | Cappello Joseph | VP, Pharmaceutical Development | Grant(A) | 13K | — | $0 |
| Mar 14, 2025 | Smalling Ralph | Head of Regulatory | Grant(A) | 4K | — | $0 |
| Jan 31, 2025 | Pulisic Matthew | Chief Financial Officer | Grant(A) | 275K | — | $0 |
| Dec 30, 2024 | Tyree James L | Director | Sell(S) | 3K | $2.46 | $9K |
| Dec 18, 2024 | Zindrick Thomas | President and CEO, Director | Grant(A) | 135K | — | $0 |
| Dec 18, 2024 | Zindrick Thomas | President and CEO, Director | Grant(A) | 183K | — | $0 |
| Dec 18, 2024 | Zak Lourie S. | Chief Financial Officer | Grant(A) | 42K | — | $0 |
| Dec 18, 2024 | Zak Lourie S. | Chief Financial Officer | Grant(A) | 57K | — | $0 |
| Dec 18, 2024 | Cappello Joseph | VP, Pharmaceutical Development | Grant(A) | 29K | — | $0 |
| Dec 18, 2024 | Cappello Joseph | VP, Pharmaceutical Development | Grant(A) | 39K | — | $0 |
| Dec 18, 2024 | Yu Yong | VP, Clinical Trial Operations | Grant(A) | 29K | — | $0 |
| Dec 18, 2024 | Yu Yong | VP, Clinical Trial Operations | Grant(A) | 39K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2020-06-29 → 2026-07-27. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).